Bienville Capital Management, LLC Abb Vie Inc. Transaction History

Bienville Capital Management, LLC

$274 Million
Q3 2024

A detailed history of Bienville Capital Management, LLC transactions in Abb Vie Inc. stock. As of the latest transaction made, Bienville Capital Management, LLC holds 4,103 shares of ABBV stock, worth $738,540. This represents 0.3% of its overall portfolio holdings.

Number of Shares

4,103

Previous 4,103 -0.0%

Holding current value

$738,540

Previous $703,000 15.22%

% of portfolio

0.3%

Previous 0.22%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 16, 2021	SELL	$105.21 - $117.21 $24,408 - $27,192	-232 Reduced 5.35%	4,103 $462,000
Q1 2021 May 17, 2021	BUY	$102.3 - $112.62 $23,733 - $26,127	232 Added 5.65%	4,335 $469,000
Q3 2020 Nov 16, 2020	SELL	$85.91 - $100.83 $154,208 - $180,989	-1,795 Reduced 30.43%	4,103 $359,000
Q2 2020 Aug 14, 2020	BUY	$73.37 - $98.18 $44,022 - $58,908	600 Added 11.33%	5,898 $579,000
Q1 2020 May 15, 2020	BUY	$64.5 - $97.79 $77,077 - $116,859	1,195 Added 29.13%	5,298 $404,000
Q3 2019 Nov 14, 2019	SELL	$62.98 - $75.72 $398,159 - $478,701	-6,322 Reduced 60.64%	4,103 $311,000
Q2 2019 Aug 14, 2019	SELL	$65.7 - $83.98 $13,074 - $16,712	-199 Reduced 1.87%	10,425 $758,000
Q1 2019 May 13, 2019	SELL	$77.14 - $90.79 $27,693 - $32,593	-359 Reduced 3.27%	10,624 $856,000
Q4 2018 Feb 13, 2019	BUY	$77.85 - $96.01 $401,939 - $495,699	5,163 Added 88.71%	10,983 $1.01 Million
Q3 2018 Nov 14, 2018	SELL	$88.91 - $98.84 $2,311 - $2,569	-26 Reduced 0.44%	5,820 $550,000
Q2 2018 Aug 08, 2018	BUY	$89.78 - $106.23 $15,621 - $18,484	174 Added 3.07%	5,846 $542,000
Q1 2018 May 15, 2018	SELL	$92.01 - $123.21 $626,864 - $839,429	-6,813 Reduced 54.57%	5,672 $537,000
Q4 2017 Feb 14, 2018	SELL	$89.56 - $98.21 $2,776 - $3,044	-31 Reduced 0.25%	12,485 $1.21 Million
Q3 2017 Nov 14, 2017	BUY	$69.85 - $89.22 $874,242 - $1.12 Million	12,516	12,516 $1.11 Million

Others Institutions Holding ABBV

# of Institutions

3,853

Shares Held

1.25B

Call Options Held

16.8M

Put Options Held

12.2M

View Full List

About AbbVie Inc.

Ticker ABBV
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,768,099,968
Market Cap $318B
Description
AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals in the worldwide. The company offers HUMIRA, a therapy administered as an injection for autoimmune and intestinal Behçet's diseases; SKYRIZI to treat moderate to severe plaque psoriasis in adults; RINVOQ, a JAK inhibitor for the treatment of moderate to severe active rheuma...

More about ABBV

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Bienville Capital Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Bienville Capital Management, LLC with notifications on news.

Account

Bienville Capital Management, LLC Abb Vie Inc. Transaction History